John P. Bilbrey - 31 Aug 2022 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Reporting relationship: Director
Issuer ticker: ELAN
Reported as of: 31 Aug 2022
Net transaction value: +$8,833
SEC form: 4
Accepted by SEC: 02 Sep 2022, 16:05:43 UTC
Prior SEC filing: 02 Aug 2022
Next SEC filing: 30 Sep 2022
Source filing: View source filing
Reporting owner signature: /s/ Marcela A. Kirberger, as Attorney-in-Fact for John P. Bilbrey

Key filing fact

John P. Bilbrey filed Form 4 for Elanco Animal Health Inc (ELAN) on 02 Sep 2022.

Key facts

This page summarizes John P. Bilbrey's Form 4 filing for Elanco Animal Health Inc (ELAN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Sep 2022, 16:05.

Change

Previous filing in this sequence was filed on 02 Aug 2022.
Current net transaction value: +$8,833.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELAN transaction Derivative

Deferred Stock Units

Award

Transaction value: $8,833
Shares: +584
Change %: +5.3%
Price: $15.13
Shares after: 11,697
Date: 31 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 584
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Footnote F2

The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

Footnote F3

The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $15.13 on August 31, 2022.